Medera's Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
Portfolio Pulse from
Medera Inc. and its subsidiary Novoheart have installed the CTScreen™ system at UMC Utrecht, enhancing cardiac disease modeling and therapeutic screening capabilities. This collaboration aims to advance human-based cardiac research and regenerative technologies.
February 10, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medera Inc. has installed its CTScreen™ system at UMC Utrecht, enhancing capabilities in cardiac disease modeling and therapy development. This collaboration could lead to advancements in cardiac research and regenerative technologies.
The installation of CTScreen™ at UMC Utrecht represents a significant step for Medera in advancing cardiac research. This collaboration could lead to new developments in cardiac disease modeling and therapy, potentially boosting Medera's reputation and market position.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80